Circular RNA hsa_circ_0000915 promotes propranolol resistance of hemangioma stem cells in infantile haemangiomas

BACKGROUND: Propranolol is a first-line clinical drug for infantile haemangiomas (IH) therapy. Nevertheless, resistance to propranolol is observed in some patients with IH. Circular RNAs (circRNAs) has been increasingly reported to act as a pivotal regulator in tumor progression. However, the underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongrang, Li, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513930/
https://www.ncbi.nlm.nih.gov/pubmed/36167680
http://dx.doi.org/10.1186/s40246-022-00416-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513930/
https://www.ncbi.nlm.nih.gov/pubmed/36167680
http://dx.doi.org/10.1186/s40246-022-00416-w

Ejemplares similares